INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 2 filers reported holding INSMED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,519 | +19.7% | 4,575 | 0.0% | 0.10% | +31.5% |
| Q2 2023 | $96,533 | +23.8% | 4,575 | 0.0% | 0.07% | +19.7% |
| Q1 2023 | $78,004 | -14.7% | 4,575 | 0.0% | 0.06% | -11.6% |
| Q4 2022 | $91,409 | -7.7% | 4,575 | 0.0% | 0.07% | -18.8% |
| Q3 2022 | $99,000 | +10.0% | 4,575 | 0.0% | 0.08% | +18.1% |
| Q2 2022 | $90,000 | -16.7% | 4,575 | 0.0% | 0.07% | 0.0% |
| Q1 2022 | $108,000 | -13.6% | 4,575 | 0.0% | 0.07% | -8.9% |
| Q4 2021 | $125,000 | -10.7% | 4,575 | -10.1% | 0.08% | -23.3% |
| Q3 2021 | $140,000 | +2.2% | 5,089 | +1.4% | 0.10% | +2.0% |
| Q2 2021 | $137,000 | +522.7% | 5,019 | +675.7% | 0.10% | +461.1% |
| Q1 2021 | $22,000 | -26.7% | 647 | -28.6% | 0.02% | -30.8% |
| Q4 2020 | $30,000 | -76.9% | 906 | -77.5% | 0.03% | -77.8% |
| Q3 2020 | $130,000 | +622.2% | 4,035 | +503.1% | 0.12% | +485.0% |
| Q2 2020 | $18,000 | +200.0% | 669 | +67.2% | 0.02% | +185.7% |
| Q1 2020 | $6,000 | -33.3% | 400 | 0.0% | 0.01% | -30.0% |
| Q4 2019 | $9,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |